April 26 (Reuters) - Medtronic PLC MDT.N:
MEDTRONIC PLC - SPHERE-360 STUDY SHOWS 88% FREEDOM FROM ARRHYTHMIA RECURRENCE
MEDTRONIC PLC - TO BEGIN U.S. PIVOTAL TRIAL FOR SPHERE-360 CATHETER
Source text: ID:nPn8dTQDQa
Further company coverage: MDT.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.